Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M438Revenue (TTM) $M6.7Net Margin (%)-1,923.1Altman Z-Score2.3
Enterprise Value $M239EPS (TTM) $-1.3Operating Margin %-1,961.8Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.4Pre-tax Margin (%)-1,923.1Higher ROA y-yY
Price/Book1.710-y EBITDA Growth Rate %--Quick Ratio11.3Cash flow > EarningsY
Price/Sales53.45-y EBITDA Growth Rate %--Current Ratio11.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-48.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M122ROIC % (ttm)-1,063.4Gross Margin Increase y-yN

Gurus Latest Trades with CLDX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

CLDX is held by these investors:



CLDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KELER TIBORExecutive VP & CSO 2016-09-02Buy3,000$3.328.13view
CATLIN AVERY WSr. VP & CFO 2015-11-23Sell25,000$18-80.06view
ELLBERGER LARRYDirector 2015-08-25Buy5,000$14-74.36view
ELLBERGER LARRYDirector 2015-08-20Buy5,000$15-76.07view
ELLBERGER LARRYDirector 2015-08-18Buy5,000$15.95-77.49view
ELLBERGER LARRYDirector 2015-08-13Buy5,000$16.59-78.36view
Marucci Anthony SPresident and CEO 2015-08-13Buy5,800$16.81-78.64view
CATLIN AVERY WSr. VP & CFO 2015-06-15Sell25,000$24.59-85.4view
van den Broek RichardDirector 2014-12-17Sell0$0-85.4view
LIPTON KAREN SHOOSDirector 2013-12-06Sell17,728$24.5-85.35view

Quarterly/Annual Reports about CLDX:

News about cldx:

Articles On GuruFocus.com
Cantor Fitzgerald and Brean Capital Positive on Celldex Therapeutics Following Positive Data For Bra Jun 01 2015 
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
Cowen & Co Remains Bullish on Celldex Therapeutics Following FDA 'Breakthrough' Approval Feb 24 2015 
CLDX up 223%, Cohen Gains Big Apr 23 2013 
Steve Cohen Increases Celldex Up 145% Apr 06 2013 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
CELLDEX THERAPEUTICS, INC (CLDX) CEO Anthony S Marucci buys 12,000 Shares Sep 13 2010 
Weekly CFO Buys Highlight: GNMK, RTIX, BKOR, PTEK, CLDX Sep 12 2010 
CELLDEX THERAPEUTICS, INC Reports Operating Results (10-Q) Aug 05 2010 

More From Other Websites
No related articles found.

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)